Effects of Hydrocortisone, Melatonin, and Placebo on Jet Lag
Jet Lag
About this trial
This is an interventional treatment trial for Jet Lag focused on measuring Cortisol, Jet Lag, Healthy Volunteer, HV
Eligibility Criteria
INCLUSION CRITERIA: Age greater than or equal to 18, but less than or equal to 65, male or female. Normal physical exam and laboratory results. Negative urinary pregnancy test 1 week prior to travel (pre-menopausal women). Planned eastward flight crossing 6-8 time zones between 30n and 50n latitudes. A minimum stay of 7 - 10 days abroad. Willingness and anticipated ability to comply with study procedures, including sleep and wake hours, saliva collection and questionnaire completion. Written informed consent. EXCLUSION CRITERIA: BMI less than or equal to 20 or greater than or equal to 30 kg/m. Current psychiatric or seizure disorder. Current sleep disorder as assessed by presence of sleep apnea, daytime napping of more than 20 minutes, chronic fatigue. History of Cushing's syndrome. Serious chronic medical condition. Current drug or alcohol abuse. SGOT or SGPT greater than three-fold normal. Current pregnancy or lactation. Current use of CPAP. Chronic use of beta-blockers (which inhibit melatonin secretion), anti-epileptic agents, anticoagulants, fluvoxamine, nifedipine or soporific or sleep-inducing agents (including benzodiazepines, melatonin), or glucocorticoids. Fasting blood glucose greater than 110 mg/dL or known diabetes.
Sites / Locations
- National Institutes of Health Clinical Center
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Placebo Comparator
Combination
Hydrocortisone
Melatonin
Placebo
Both HC 30 and ML 5 will be administered
30mg Hydrocortisone will be administered
5 mg Melatonin will be administered
Placebo